Literature DB >> 27404231

The Ayurvedic Pharmacopoeia of India, development and perspectives.

Vinod Kumar Joshi1, Apurva Joshi2, Kartar Singh Dhiman3.   

Abstract

ETHNOPHARMACOLOGICAL RELEVANCE: The Ayurvedic Pharmacopoeia of India (API) is a unique book of standards describing the quality, purity and strength of selected drugs that are manufactured, distributed, and sold by the licensed manufacturers in pan India. It is developed in two parts; the part one comprises of mono-monographs of medicinal substances of natural origin and part two includes selected compound formulations sourced from the schedule - I books under the Drugs and Cosmetics Act, 1940 comprising of popular Ayurvedic classics of different period of times. The first part of the Ayurvedic Formulary of India was published in 1978 and thereafter, the Ayurvedic Pharmacopoeia of India (mono-monograph) Part-I, Vol. I was published in the year 1989 and subsequently, the other volumes were published with their legalized status under Drugs and Cosmetics Act, 1940. AIM OF THE STUDY: The study was aimed to bring out the existing knowledge on the Ayurvedic pharmacopoeia with its chronological development reviewed from the ancient Vedic Compendia with its continuum in Ayurvedic classics of different period of time till recent past.
MATERIALS AND METHODS: A literary search based on the ancient origin of Ayurveda was carried out. The drug making from the natural resources and utility of the knowledge exist in classical Ayurvedic works of different period of time till composition of the Ayurvedic Pharmacopoeia of India and its importance as official documents of Govt. of India for Standards of Ayurvedic Drugs and its perspectives have been discussed.
RESULTS: The present paper reviews on the systemic development and different aspects of drug-making (Pharmacopoeia) with evidence lying in the 5000 years old work of India. During the systematic review of the various works of different period of times (ancient, medieval and modern), it was found that the Ayurvedic Pharmacopoeia of India has its development during 20th Century as an official document of Govt. of India comprising of single drugs monograph and compound formulations.
CONCLUSION: In India, the development of the Indian Pharmacopoeia started in 20th Century on the recommendation of the Col. R.N. Chopra Committee and in 1978 the first part of the Ayurvedic formulary of India was published. Subsequently, the amendment in the drugs and cosmetics Act 1940 was brought in 1964 for regulation of the drugs in Indian Systems of Medicine (Ayurveda, Unani and Siddha). Later on the Ayurvedic Pharmacopoeia of India (Mono-Monograph) Part-I, Volume I, was published in the year 1989 and the other volumes were published subsequently in different years.
Copyright © 2016 Elsevier Ireland Ltd. All rights reserved.

Keywords:  Ayurveda; Ayurvedic Pharmacopoeia; Charaka Samhita; Drug-making; Susruta Samhita; Veda

Mesh:

Year:  2016        PMID: 27404231     DOI: 10.1016/j.jep.2016.07.030

Source DB:  PubMed          Journal:  J Ethnopharmacol        ISSN: 0378-8741            Impact factor:   4.360


  9 in total

1.  Quantification of adulteration in traded ayurvedic raw drugs employing machine learning approaches with DNA barcode database.

Authors:  Suma Arun Dev; Remya Unnikrishnan; R Jayaraj; P Sujanapal; V Anitha
Journal:  3 Biotech       Date:  2021-10-18       Impact factor: 2.406

2.  Polymeric Microsphere Formulation for Colon Targeted Delivery of 5-Fluorouracil Using Biocompatible Natural Gum Katira.

Authors:  Saumen Karan; Hira Choudhury; Biplab Kumar Chakra; Tapan Kumar Chatterjee
Journal:  Asian Pac J Cancer Prev       Date:  2019-07-01

Review 3.  A review on antiviral and immunomodulatory polysaccharides from Indian medicinal plants, which may be beneficial to COVID-19 infected patients.

Authors:  Ipsita Kumar Sen; Indranil Chakraborty; Amit Kumar Mandal; Sunil Kumar Bhanja; Sukesh Patra; Prasenjit Maity
Journal:  Int J Biol Macromol       Date:  2021-03-29       Impact factor: 8.025

Review 4.  Antiviral and Immunomodulation Effects of Artemisia.

Authors:  Suhas G Kshirsagar; Rammohan V Rao
Journal:  Medicina (Kaunas)       Date:  2021-02-27       Impact factor: 2.430

5.  Mechanistic insights from the review and evaluation of ayurvedic herbal medicines for the prevention and management of COVID-19 patients.

Authors:  Prasanta Kumar Sarkar; Chitrangada Das Mukhopadhyay
Journal:  J Herb Med       Date:  2022-02-18       Impact factor: 3.032

Review 6.  A Brief Overview of Potential Treatments for Viral Diseases Using Natural Plant Compounds: The Case of SARS-Cov.

Authors:  Rambod Abiri; Hazandy Abdul-Hamid; Oksana Sytar; Ramin Abiri; Eduardo Bezerra de Almeida; Surender K Sharma; Victor P Bulgakov; Randolph R J Arroo; Sonia Malik
Journal:  Molecules       Date:  2021-06-24       Impact factor: 4.411

Review 7.  Ayurveda and medicalisation today: The loss of important knowledge and practice in health?

Authors:  Mahesh Madhav Mathpati; Sandra Albert; John D H Porter
Journal:  J Ayurveda Integr Med       Date:  2018-11-17

8.  Evaluation of antimicrobial properties of Solanum xanthocarpum and Pistacia lentiscus extracts on Streptococcus mutans, Lactobacillus species and Actinomyces viscosus: An in vitro study.

Authors:  Panjanathan Mahalakshmi; Annasamy Rameshkumar; Gunasekaran Sudha; Thayalan Dineshkumar; Haridass Vinoth; Ada Malar
Journal:  J Oral Maxillofac Pathol       Date:  2019 Sep-Dec

9.  In Vitro Phytochemical Screening, Cytotoxicity Studies of Curcuma longa Extracts with Isolation and Characterisation of Their Isolated Compounds.

Authors:  Madhuri Grover; Tapan Behl; Aayush Sehgal; Sukhbir Singh; Neelam Sharma; Tarun Virmani; Mahesh Rachamalla; Abdullah Farasani; Sridevi Chigurupati; Amal M Alsubayiel; Shatha Ghazi Felemban; Mohit Sanduja; Simona Bungau
Journal:  Molecules       Date:  2021-12-11       Impact factor: 4.411

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.